The Efficacy of Acupuncture and Fu's Subcutaneous Needling (FSN ) in Treating Chronic Tension-type Headache by fMRI
To Explore the Cerebral Function Efficacy of Acupuncture and Fu's Subcutaneous Needling (FSN) in the Treatment of Chronic Tension-type Headache by Means of fMRI: a Single-blinded, Randomized Controlled Trials.
1 other identifier
interventional
45
0 countries
N/A
Brief Summary
Epidemiological studies show a one-year prevalence of 30%-60% for episodic tension-type headache (TTH) and 2%-3% for chronic TTH (CTTH). Many TTH patients seek acupuncture treatment worldwide, and CTTH is one of the most commonly treated. FSN has been used to treat CTTH recently; the curative effect of it was especially good for CTTH accompanying pericranial tenderness. Nonetheless, the effectiveness of acupuncture and FSN for CTTH remains controversial. Several research results showed that symptoms of TTH improve after acupuncture treatment, but these improvements were more subjective than objective measures. So, the aim of this study is to determine the cerebral function efficacy of acupuncture and FSN in the treatment of CTTH, using Headache impact test questionnaire (HIT-6), VAS to evaluate the subjective symptom and fMRI to detect the objective cerebral function changes. Intervention: device: acupuncture; Fu's subcutaneous; placebo sham acupuncture
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2017
CompletedFirst Posted
Study publicly available on registry
May 31, 2017
CompletedStudy Start
First participant enrolled
June 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedJune 5, 2017
May 1, 2017
5 months
May 4, 2017
June 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes of Regional homogeneity data (ReHo) (using Kendall's coefficient of concordance as index) of Resting state fMRI of the whole brain (from the Vertex to Basicranial)
ReHo data before and after the first/last, as well as after the fourth acupuncture, FSN and sham acupuncture treatment, Changes of ReHo data from baseline to after the first, fourth, last treatment will be calculated in each treatment group and will be compared with each other.
5 months
Secondary Outcomes (2)
Pain Visual Analogue Scale (VAS)
4 months.
Headache Impact Test (HIT-6)
4 months.
Study Arms (3)
Acupuncture
EXPERIMENTALAcupuncture at acupoints for CTTH according to TCM theory, twice 1 week for 4 weeks,fMRI will be used to detect the cerebral function changes
Fu's subcutaneous needling (FSN)
ACTIVE COMPARATORFSN at the points related with CTTH, twice 1 week for 4 weeks, fMRI will be used to detect the cerebral function changes.
Sham acupuncture
SHAM COMPARATORStreitberger placebo needles at nonacupoint for CTTH, twice 1 week for 4 weeks,fMRI will be used to detect the cerebral function changes.
Interventions
Acupuncture at acupoints for CTTH according to TCM theory using stainless filiform needle.
Fu's subcutaneous needling at specific points for CTTH using soft casing needle.
Sham acupuncture at non-acupoints using Steinberger placebo needles
Eligibility Criteria
You may qualify if:
- Conforms to clinical diagnostic criteria of CTTH associated with pericranial tenderness(ICHD-3 beta version), Han nationality.
- Aged between 18 and 45 years old men or women with right-handed.
- No history of cognitive dysfunction.
- Seeking medical advice for TTH for the first time.
- Providing informed consent to participate in the study.
You may not qualify if:
- Taking analgesics or other drugs may affect the resting state fMRI scans of brain within two weeks.
- Have hypertension, diabetes, anxiety, depression and other systemic diseases, other chronic pain etc. Psychiatric or neurologic disorder that unable patient to consent and follow study protocol.
- Combined with other type headache.
- Intracranial lesions are found in MRI or CT scans.
- Headache breaks out within 24h after fMRI scan.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Zhouyi Guo, Pro
SATCM Third Grade Laboratory of Chinese Medicine and Photonics Technology, College of Biophotonics and fMRI chamber, research resources center, South China Normal University.
- PRINCIPAL INVESTIGATOR
Jian Sun, PhD
Traditional therapy center, Guangdong Hospital of Traditional Chinese Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Postdoctor;Lecturer
Study Record Dates
First Submitted
May 4, 2017
First Posted
May 31, 2017
Study Start
June 10, 2017
Primary Completion
October 31, 2017
Study Completion
December 31, 2017
Last Updated
June 5, 2017
Record last verified: 2017-05